These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7865098)

  • 1. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated.
    Ogren SO; Goldstein M
    Neuropsychopharmacology; 1994 Nov; 11(3):167-77. PubMed ID: 7865098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP; Rogawski MA
    Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
    Cook CD; Newman JL; Winfree JC; Beardsley PM
    Pharmacol Biochem Behav; 2004 Feb; 77(2):309-18. PubMed ID: 14751459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle.
    Keith VA; Mansbach RS; Geyer MA
    Biol Psychiatry; 1991 Sep; 30(6):557-66. PubMed ID: 1834231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.
    Chartoff EH; Heusner CL; Palmiter RD
    Neuropsychopharmacology; 2005 Jul; 30(7):1324-33. PubMed ID: 15688082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
    Dall'olio R; Rimondini R; Gandolfi O
    Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.
    Johansson C; Jackson DM; Svensson L
    Psychopharmacology (Berl); 1994 Dec; 116(4):437-42. PubMed ID: 7701046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
    Svensson A; Carlsson A; Carlsson ML
    J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine supersensitivity in rats with neonatal dopamine loss.
    Moy SS; Breese GR
    Psychopharmacology (Berl); 2002 May; 161(3):255-62. PubMed ID: 12021828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats.
    Jackson DM; Johansson C; Lindgren LM; Bengtsson A
    Pharmacol Biochem Behav; 1994 Jun; 48(2):465-71. PubMed ID: 8090816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
    Bakshi VP; Swerdlow NR; Geyer MA
    J Pharmacol Exp Ther; 1994 Nov; 271(2):787-94. PubMed ID: 7965797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: the roles of glutamate, dopamine, acetylcholine and corticosteroids.
    Griffiths MR; Cooper AJ; Barber DJ; Mitchell IJ
    Brain Res; 2000 Feb; 855(1):1-10. PubMed ID: 10650124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats.
    Yokoyama O; Yoshiyama M; Namiki M; de Groat WC
    Exp Neurol; 2002 Jan; 173(1):129-35. PubMed ID: 11771945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.
    Del Arco A; Mora F; Mohammed AH; Fuxe K
    J Neural Transm (Vienna); 2007 Feb; 114(2):185-93. PubMed ID: 16897609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between D2 dopaminergic and glutamatergic excitatory influences on lower urinary tract function in normal and cerebral-infarcted rats.
    Yokoyama O; Yoshiyama M; Namiki M; de Groat WC
    Exp Neurol; 2001 May; 169(1):148-55. PubMed ID: 11312567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.